On November 5, Hims & Hers Health Inc. fell 5.18% in Regular Trading, trading at $24.275 per share, with turnover of $61.6768 million.
The latest market focus remained on the company’s FTC-related complaint and consumer billing controversy, which continued to pressure short-term risk appetite despite the company’s request that a federal judge dismiss the case.
Recent reports said the complaint alleges Hims & Hers Health Inc. misled consumers about products and charged for unwanted subscriptions. Separately, its weight-loss subscription business had previously faced a surge in credit-card disputes, including notice of roughly $75,000 in related fees, adding to investor concerns around compliance, customer retention, and operating execution ahead of its November 9 earnings release.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments